These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 18451140

  • 1. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG.
    Cancer Res; 2008 May 01; 68(9):3152-60. PubMed ID: 18451140
    [Abstract] [Full Text] [Related]

  • 2. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 01; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C, Lu YH, Xie JH, Wang F, Zou JN, Yang JS, Xing YY, Xi T.
    Anticancer Drugs; 2009 Apr 01; 20(4):249-58. PubMed ID: 19174695
    [Abstract] [Full Text] [Related]

  • 4. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
    Liu Y, Chen L, Ko TC, Fields AP, Thompson EA.
    Oncogene; 2006 Jun 15; 25(25):3565-75. PubMed ID: 16462766
    [Abstract] [Full Text] [Related]

  • 5. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 15; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 6. Activation of the PI3K/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.
    Huang Y, Hua K, Zhou X, Jin H, Chen X, Lu X, Yu Y, Zha X, Feng Y.
    Cell Res; 2008 Jul 15; 18(7):780-91. PubMed ID: 18574502
    [Abstract] [Full Text] [Related]

  • 7. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.
    Oncogene; 2007 Aug 02; 26(35):5046-59. PubMed ID: 17310986
    [Abstract] [Full Text] [Related]

  • 8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE, Wang MX, Li RQ.
    Cancer Invest; 2009 Jul 02; 27(6):604-12. PubMed ID: 19440933
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 10. Raptor-rictor axis in TGFbeta-induced protein synthesis.
    Das F, Ghosh-Choudhury N, Mahimainathan L, Venkatesan B, Feliers D, Riley DJ, Kasinath BS, Choudhury GG.
    Cell Signal; 2008 Feb 15; 20(2):409-23. PubMed ID: 18068336
    [Abstract] [Full Text] [Related]

  • 11. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M, Latham DE, Delaney MA, Chakravarti A.
    Oncogene; 2005 Apr 07; 24(15):2474-82. PubMed ID: 15735703
    [Abstract] [Full Text] [Related]

  • 12. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 13. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells.
    Solovyan VT, Keski-Oja J.
    J Cell Physiol; 2006 May 01; 207(2):445-53. PubMed ID: 16447253
    [Abstract] [Full Text] [Related]

  • 14. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas.
    Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH.
    Cancer Res; 2008 Jul 01; 68(13):5159-66. PubMed ID: 18593915
    [Abstract] [Full Text] [Related]

  • 15. Prevention of TGF-beta-induced apoptosis by interlukin-4 through Akt activation and p70S6K survival signaling pathways.
    Lin SJ, Chang C, Ng AK, Wang SH, Li JJ, Hu CP.
    Apoptosis; 2007 Sep 01; 12(9):1659-70. PubMed ID: 17624592
    [Abstract] [Full Text] [Related]

  • 16. The modulation of apoptosis by cyclic AMP involves Akt and epidermal growth factor receptor.
    Zhou B, Li F, Chen H, Song J.
    Int J Biochem Cell Biol; 2005 Jul 01; 37(7):1483-95. PubMed ID: 15833279
    [Abstract] [Full Text] [Related]

  • 17. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy.
    McKay TR, Bell S, Tenev T, Stoll V, Lopes R, Lemoine NR, McNeish IA.
    Oncogene; 2003 Jun 05; 22(23):3539-47. PubMed ID: 12789262
    [Abstract] [Full Text] [Related]

  • 18. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 19. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.
    Simms NA, Rajput A, Sharratt EA, Ongchin M, Teggart CA, Wang J, Brattain MG.
    BMC Cancer; 2012 Jun 06; 12():221. PubMed ID: 22672900
    [Abstract] [Full Text] [Related]

  • 20. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK, Beauchamp RD, Datta PK.
    Exp Cell Res; 2005 Jul 01; 307(1):231-46. PubMed ID: 15922743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.